CHANGE LANGUAGE

FARMIGEA'S TEAR SUBSTITUTE LANDS IN LATIN AMERICA
FARMIGEA'S TEAR SUBSTITUTE LANDS IN LATIN AMERICA
FARMIGEA'S TEAR SUBSTITUTE LANDS IN LATIN AMERICA
FARMIGEA'S TEAR SUBSTITUTE LANDS IN LATIN AMERICA
FARMIGEA'S TEAR SUBSTITUTE LANDS IN LATIN AMERICA
Slider

Farmigea together with its new commercial partner Laboratorios Grin will land with its ophthalmic products in Latin America.

Mappa Messico

Thanks to the collaboration with Laboratorios Grin, an affiliate of Lupin GroupFarmigea is expanding its ophthalmic product list in Mexico with the registration of a 10ml multidose preservative free tear substitute containing Hyaluronic Acid that will be launched on the market in 2019 under the brand name Zonaker PF, enriching with a new reference the local well-known Zonaker line of products dedicated to the eye care, with the aim of improving the quality and the variety of the treatments for patients suffering of ocular discomfort.

LABORATORIOS GRIN

Logo Laboratorios Grin

Laboratorios Grin is an ophthalmic company of the Lupine group, established in 1953 in Mexico and employing 270 people. The company deals with the research, production and distribution of drugs worldwide with the aim of contributing to the prevention and treatment of ophthalmic diseases by providing doctors with reliable and effective products. Laboratorios Grin works to become the main Mexican laboratory in the field of ophthalmology and to be internationally recognized as a producer and distributor of high-quality products.